recombinant human arylsulfatase A (HGT-1111)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant human arylsulfatase A (HGT-1111), covering 2013-11-08 to 2013-11-08. Get the full timeline:
Most recent: Clinical Trial Update: Open-Label Extension Study of Recombinant Human Arylsulfatase A (HGT-1111) in Late Infantile MLD [Phase 2]